A Phase I Randomized, Placebo-Controlled, Double-Blind, Dose Ranging Study of the Safety, Tolerability and Immunogenicity of a Clostridium difficile Toxoid Vaccine, Alum Adsorbed, in Healthy Adult volunteers (18-55 years)

Grants and Contracts Details

StatusFinished
Effective start/end date5/23/05 → 1/31/13

Funding

  • Acambis Inc: $15,261.00